{"transactions":[{"id":2063440,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":120941,"kind":"person","name":"InvOpps GP IV, L.L.C.","position":1,"cik":"0001792570","reported_name":"InvOpps GP IV, L.L.C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120942,"kind":"person","name":"InvOpps IV, L.P.","position":2,"cik":"0001792575","reported_name":"InvOpps IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120943,"kind":"person","name":"InvOpps IV US, L.P.","position":3,"cik":"0001745076","reported_name":"InvOpps IV US, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120944,"kind":"person","name":"LAINOVIC SACHA","position":4,"cik":"0001053891","reported_name":"LAINOVIC SACHA","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2023-01-05T16:30:58.000Z","date":"2023-01-03","kind":"other","acquired":false,"shares":1850818,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to that certain Agreement and Plan of Merger (the \"Merger Agreement\") by and among Viatris Inc. (\"Viatris\") and Viatris's wholly owned subsidiary, Iris Purchaser Inc. dated as of November 7, 2022, these shares of common stock, par value $0.001 per share were tendered prior to the Offer Expiration Time (as defined in the Merger Agreement) and disposed of at the Effective Time (as defined in the Merger Agreement) in exchange for the right to receive (a) a cash payment of $11.00 per share (the \"Cash Amount\") and (b) one non-transferable contractual contingent value right representing the right to receive any applicable milestone payment if specified milestones are achieved pursuant to a Contingent Value Rights Agreement, dated January 3, 2023, by and between Viatris and American Stock Transfer & Trust Company, LLC as Rights Agent."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to that certain Agreement and Plan of Merger (the \"Merger Agreement\") by and among Viatris Inc. (\"Viatris\") and Viatris's wholly owned subsidiary, Iris Purchaser Inc. dated as of November 7, 2022, these shares of common stock, par value $0.001 per share were tendered prior to the Offer Expiration Time (as defined in the Merger Agreement) and disposed of at the Effective Time (as defined in the Merger Agreement) in exchange for the right to receive (a) a cash payment of $11.00 per share (the \"Cash Amount\") and (b) one non-transferable contractual contingent value right representing the right to receive any applicable milestone payment if specified milestones are achieved pursuant to a Contingent Value Rights Agreement, dated January 3, 2023, by and between Viatris and American Stock Transfer & Trust Company, LLC as Rights Agent."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Reflects securities directly held by InvOpps IV, L.P. (\"Invus IV\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"InvOpps GP IV, L.L.C. (\"InvOpps GP\") is the sole general partner of each of Invus IV and Invus IV US. Sacha Lainovic is the managing member of InvOpps GP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Each of the Reporting Persons (other than to the extent it directly holds securities reported herein) disclaims beneficial ownership of the securities held by the other Reporting Persons, except to the extent of such Reporting Person's pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), each of the Reporting Persons (other than to the extent it directly holds securities reported herein) states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-23-000999","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1053891/000089924323000999/doc4.xml","form_type":"4"}},{"id":2063439,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":120941,"kind":"person","name":"InvOpps GP IV, L.L.C.","position":1,"cik":"0001792570","reported_name":"InvOpps GP IV, L.L.C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120942,"kind":"person","name":"InvOpps IV, L.P.","position":2,"cik":"0001792575","reported_name":"InvOpps IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120943,"kind":"person","name":"InvOpps IV US, L.P.","position":3,"cik":"0001745076","reported_name":"InvOpps IV US, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120944,"kind":"person","name":"LAINOVIC SACHA","position":4,"cik":"0001053891","reported_name":"LAINOVIC SACHA","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2023-01-05T16:30:58.000Z","date":"2023-01-03","kind":"other","acquired":false,"shares":917768,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to that certain Agreement and Plan of Merger (the \"Merger Agreement\") by and among Viatris Inc. (\"Viatris\") and Viatris's wholly owned subsidiary, Iris Purchaser Inc. dated as of November 7, 2022, these shares of common stock, par value $0.001 per share were tendered prior to the Offer Expiration Time (as defined in the Merger Agreement) and disposed of at the Effective Time (as defined in the Merger Agreement) in exchange for the right to receive (a) a cash payment of $11.00 per share (the \"Cash Amount\") and (b) one non-transferable contractual contingent value right representing the right to receive any applicable milestone payment if specified milestones are achieved pursuant to a Contingent Value Rights Agreement, dated January 3, 2023, by and between Viatris and American Stock Transfer & Trust Company, LLC as Rights Agent."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to that certain Agreement and Plan of Merger (the \"Merger Agreement\") by and among Viatris Inc. (\"Viatris\") and Viatris's wholly owned subsidiary, Iris Purchaser Inc. dated as of November 7, 2022, these shares of common stock, par value $0.001 per share were tendered prior to the Offer Expiration Time (as defined in the Merger Agreement) and disposed of at the Effective Time (as defined in the Merger Agreement) in exchange for the right to receive (a) a cash payment of $11.00 per share (the \"Cash Amount\") and (b) one non-transferable contractual contingent value right representing the right to receive any applicable milestone payment if specified milestones are achieved pursuant to a Contingent Value Rights Agreement, dated January 3, 2023, by and between Viatris and American Stock Transfer & Trust Company, LLC as Rights Agent."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects securities directly held by InvOpps IV US, L.P. (\"Invus IV US\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"InvOpps GP IV, L.L.C. (\"InvOpps GP\") is the sole general partner of each of Invus IV and Invus IV US. Sacha Lainovic is the managing member of InvOpps GP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Each of the Reporting Persons (other than to the extent it directly holds securities reported herein) disclaims beneficial ownership of the securities held by the other Reporting Persons, except to the extent of such Reporting Person's pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), each of the Reporting Persons (other than to the extent it directly holds securities reported herein) states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-23-000999","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053891/000089924323000999/doc4.xml","form_type":"4"}},{"id":3139470,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":120941,"kind":"person","name":"InvOpps GP IV, L.L.C.","position":1,"cik":"0001792570","reported_name":"InvOpps GP IV, L.L.C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120942,"kind":"person","name":"InvOpps IV, L.P.","position":2,"cik":"0001792575","reported_name":"InvOpps IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120943,"kind":"person","name":"InvOpps IV US, L.P.","position":3,"cik":"0001745076","reported_name":"InvOpps IV US, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120944,"kind":"person","name":"LAINOVIC SACHA","position":4,"cik":"0001053891","reported_name":"LAINOVIC SACHA","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2020-05-21T17:00:15.000Z","date":"2020-05-19","kind":"purchase","acquired":true,"shares":119393,"price":28,"value":3343004.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects securities directly held by InvOpps IV, L.P. (\"Invus IV\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"InvOpps GP IV, L.L.C. (\"InvOpps GP\") is the sole general partner of each of Invus IV and Invus IV US. Sacha Lainovic is the managing member of InvOpps GP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each of the Reporting Persons (other than to the extent it directly holds securities reported herein) disclaims beneficial ownership of the securities held by the other Reporting Persons, except to the extent of such Reporting Person's pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), each of the Reporting Persons (other than to the extent it directly holds securities reported herein) states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":1850818,"source":{"system":"sec-edgar","filing":"0000899243-20-013881","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1053891/000089924320013881/doc4.xml","form_type":"4"}},{"id":3139469,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":120941,"kind":"person","name":"InvOpps GP IV, L.L.C.","position":1,"cik":"0001792570","reported_name":"InvOpps GP IV, L.L.C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120942,"kind":"person","name":"InvOpps IV, L.P.","position":2,"cik":"0001792575","reported_name":"InvOpps IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120943,"kind":"person","name":"InvOpps IV US, L.P.","position":3,"cik":"0001745076","reported_name":"InvOpps IV US, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120944,"kind":"person","name":"LAINOVIC SACHA","position":4,"cik":"0001053891","reported_name":"LAINOVIC SACHA","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2020-05-21T17:00:15.000Z","date":"2020-05-19","kind":"purchase","acquired":true,"shares":59178,"price":28,"value":1656984.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Reflects securities directly held by InvOpps IV US, L.P. (\"Invus IV US\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"InvOpps GP IV, L.L.C. (\"InvOpps GP\") is the sole general partner of each of Invus IV and Invus IV US. Sacha Lainovic is the managing member of InvOpps GP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each of the Reporting Persons (other than to the extent it directly holds securities reported herein) disclaims beneficial ownership of the securities held by the other Reporting Persons, except to the extent of such Reporting Person's pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), each of the Reporting Persons (other than to the extent it directly holds securities reported herein) states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":917768,"source":{"system":"sec-edgar","filing":"0000899243-20-013881","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053891/000089924320013881/doc4.xml","form_type":"4"}},{"id":3378980,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":120941,"kind":"person","name":"InvOpps GP IV, L.L.C.","position":1,"cik":"0001792570","reported_name":"InvOpps GP IV, L.L.C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120942,"kind":"person","name":"InvOpps IV, L.P.","position":2,"cik":"0001792575","reported_name":"InvOpps IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120943,"kind":"person","name":"InvOpps IV US, L.P.","position":3,"cik":"0001745076","reported_name":"InvOpps IV US, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120944,"kind":"person","name":"LAINOVIC SACHA","position":4,"cik":"0001053891","reported_name":"LAINOVIC SACHA","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2019-11-06T16:30:33.000Z","date":"2019-11-04","kind":"exercise","acquired":false,"shares":1230050,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"These shares of Series B Convertible Preferred Stock automatically converted into shares of the Issuer's common stock (the \"Common Stock\"), on a one-for-one basis, immediately prior to the completion of the Issuer's initial public offering. The Series B Convertible Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares of Series B Convertible Preferred Stock automatically converted into shares of the Issuer's common stock (the \"Common Stock\"), on a one-for-one basis, immediately prior to the completion of the Issuer's initial public offering. The Series B Convertible Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These shares of Series B Convertible Preferred Stock automatically converted into shares of the Issuer's common stock (the \"Common Stock\"), on a one-for-one basis, immediately prior to the completion of the Issuer's initial public offering. The Series B Convertible Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"These shares of Series B Convertible Preferred Stock automatically converted into shares of the Issuer's common stock (the \"Common Stock\"), on a one-for-one basis, immediately prior to the completion of the Issuer's initial public offering. The Series B Convertible Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Reflects securities directly held by InvOpps IV, L.P. (\"Invus IV\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"InvOpps GP IV, L.L.C. (\"InvOpps GP\") is the sole general partner of each of Invus IV and Invus IV US. Sacha Lainovic is the managing member of InvOpps GP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Each of the Reporting Persons (other than to the extent it directly holds securities reported herein) disclaims beneficial ownership of the securities held by the other Reporting Persons, except to the extent of such Reporting Person's pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), each of the Reporting Persons (other than to the extent it directly holds securities reported herein) states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock, par value $0.001 per share","underlying_shares":1230050},"source":{"system":"sec-edgar","filing":"0000899243-19-026771","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1053891/000089924319026771/doc4.xml","form_type":"4"}},{"id":3378979,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":120941,"kind":"person","name":"InvOpps GP IV, L.L.C.","position":1,"cik":"0001792570","reported_name":"InvOpps GP IV, L.L.C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120942,"kind":"person","name":"InvOpps IV, L.P.","position":2,"cik":"0001792575","reported_name":"InvOpps IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120943,"kind":"person","name":"InvOpps IV US, L.P.","position":3,"cik":"0001745076","reported_name":"InvOpps IV US, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120944,"kind":"person","name":"LAINOVIC SACHA","position":4,"cik":"0001053891","reported_name":"LAINOVIC SACHA","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2019-11-06T16:30:33.000Z","date":"2019-11-04","kind":"exercise","acquired":false,"shares":609965,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"These shares of Series B Convertible Preferred Stock automatically converted into shares of the Issuer's common stock (the \"Common Stock\"), on a one-for-one basis, immediately prior to the completion of the Issuer's initial public offering. The Series B Convertible Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares of Series B Convertible Preferred Stock automatically converted into shares of the Issuer's common stock (the \"Common Stock\"), on a one-for-one basis, immediately prior to the completion of the Issuer's initial public offering. The Series B Convertible Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These shares of Series B Convertible Preferred Stock automatically converted into shares of the Issuer's common stock (the \"Common Stock\"), on a one-for-one basis, immediately prior to the completion of the Issuer's initial public offering. The Series B Convertible Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"These shares of Series B Convertible Preferred Stock automatically converted into shares of the Issuer's common stock (the \"Common Stock\"), on a one-for-one basis, immediately prior to the completion of the Issuer's initial public offering. The Series B Convertible Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects securities directly held by InvOpps IV US, L.P. (\"Invus IV US\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"InvOpps GP IV, L.L.C. (\"InvOpps GP\") is the sole general partner of each of Invus IV and Invus IV US. Sacha Lainovic is the managing member of InvOpps GP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Each of the Reporting Persons (other than to the extent it directly holds securities reported herein) disclaims beneficial ownership of the securities held by the other Reporting Persons, except to the extent of such Reporting Person's pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), each of the Reporting Persons (other than to the extent it directly holds securities reported herein) states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock, par value $0.001 per share","underlying_shares":609965},"source":{"system":"sec-edgar","filing":"0000899243-19-026771","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1053891/000089924319026771/doc4.xml","form_type":"4"}},{"id":3378978,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":120941,"kind":"person","name":"InvOpps GP IV, L.L.C.","position":1,"cik":"0001792570","reported_name":"InvOpps GP IV, L.L.C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120942,"kind":"person","name":"InvOpps IV, L.P.","position":2,"cik":"0001792575","reported_name":"InvOpps IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120943,"kind":"person","name":"InvOpps IV US, L.P.","position":3,"cik":"0001745076","reported_name":"InvOpps IV US, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120944,"kind":"person","name":"LAINOVIC SACHA","position":4,"cik":"0001053891","reported_name":"LAINOVIC SACHA","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2019-11-06T16:30:33.000Z","date":"2019-11-04","kind":"purchase","acquired":true,"shares":501375,"price":16,"value":8022000.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Reflects securities directly held by InvOpps IV, L.P. (\"Invus IV\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"InvOpps GP IV, L.L.C. (\"InvOpps GP\") is the sole general partner of each of Invus IV and Invus IV US. Sacha Lainovic is the managing member of InvOpps GP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Each of the Reporting Persons (other than to the extent it directly holds securities reported herein) disclaims beneficial ownership of the securities held by the other Reporting Persons, except to the extent of such Reporting Person's pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), each of the Reporting Persons (other than to the extent it directly holds securities reported herein) states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":1731425,"source":{"system":"sec-edgar","filing":"0000899243-19-026771","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1053891/000089924319026771/doc4.xml","form_type":"4"}},{"id":3378977,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":120941,"kind":"person","name":"InvOpps GP IV, L.L.C.","position":1,"cik":"0001792570","reported_name":"InvOpps GP IV, L.L.C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120942,"kind":"person","name":"InvOpps IV, L.P.","position":2,"cik":"0001792575","reported_name":"InvOpps IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120943,"kind":"person","name":"InvOpps IV US, L.P.","position":3,"cik":"0001745076","reported_name":"InvOpps IV US, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120944,"kind":"person","name":"LAINOVIC SACHA","position":4,"cik":"0001053891","reported_name":"LAINOVIC SACHA","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2019-11-06T16:30:33.000Z","date":"2019-11-04","kind":"purchase","acquired":true,"shares":248625,"price":16,"value":3978000.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects securities directly held by InvOpps IV US, L.P. (\"Invus IV US\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"InvOpps GP IV, L.L.C. (\"InvOpps GP\") is the sole general partner of each of Invus IV and Invus IV US. Sacha Lainovic is the managing member of InvOpps GP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Each of the Reporting Persons (other than to the extent it directly holds securities reported herein) disclaims beneficial ownership of the securities held by the other Reporting Persons, except to the extent of such Reporting Person's pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), each of the Reporting Persons (other than to the extent it directly holds securities reported herein) states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":858590,"source":{"system":"sec-edgar","filing":"0000899243-19-026771","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1053891/000089924319026771/doc4.xml","form_type":"4"}},{"id":3378976,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":120941,"kind":"person","name":"InvOpps GP IV, L.L.C.","position":1,"cik":"0001792570","reported_name":"InvOpps GP IV, L.L.C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120942,"kind":"person","name":"InvOpps IV, L.P.","position":2,"cik":"0001792575","reported_name":"InvOpps IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120943,"kind":"person","name":"InvOpps IV US, L.P.","position":3,"cik":"0001745076","reported_name":"InvOpps IV US, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120944,"kind":"person","name":"LAINOVIC SACHA","position":4,"cik":"0001053891","reported_name":"LAINOVIC SACHA","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2019-11-06T16:30:33.000Z","date":"2019-11-04","kind":"exercise","acquired":true,"shares":1230050,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares of Series B Convertible Preferred Stock automatically converted into shares of the Issuer's common stock (the \"Common Stock\"), on a one-for-one basis, immediately prior to the completion of the Issuer's initial public offering. The Series B Convertible Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Reflects securities directly held by InvOpps IV, L.P. (\"Invus IV\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"InvOpps GP IV, L.L.C. (\"InvOpps GP\") is the sole general partner of each of Invus IV and Invus IV US. Sacha Lainovic is the managing member of InvOpps GP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Each of the Reporting Persons (other than to the extent it directly holds securities reported herein) disclaims beneficial ownership of the securities held by the other Reporting Persons, except to the extent of such Reporting Person's pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), each of the Reporting Persons (other than to the extent it directly holds securities reported herein) states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":1230050,"source":{"system":"sec-edgar","filing":"0000899243-19-026771","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1053891/000089924319026771/doc4.xml","form_type":"4"}},{"id":3378975,"issuer":{"id":15903,"kind":"organization","name":"Oyster Point Pharma, Inc.","symbol":"OYST"},"owners":[{"id":120941,"kind":"person","name":"InvOpps GP IV, L.L.C.","position":1,"cik":"0001792570","reported_name":"InvOpps GP IV, L.L.C.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120942,"kind":"person","name":"InvOpps IV, L.P.","position":2,"cik":"0001792575","reported_name":"InvOpps IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120943,"kind":"person","name":"InvOpps IV US, L.P.","position":3,"cik":"0001745076","reported_name":"InvOpps IV US, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":120944,"kind":"person","name":"LAINOVIC SACHA","position":4,"cik":"0001053891","reported_name":"LAINOVIC SACHA","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2019-11-06T16:30:33.000Z","date":"2019-11-04","kind":"exercise","acquired":true,"shares":609965,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares of Series B Convertible Preferred Stock automatically converted into shares of the Issuer's common stock (the \"Common Stock\"), on a one-for-one basis, immediately prior to the completion of the Issuer's initial public offering. The Series B Convertible Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Reflects securities directly held by InvOpps IV US, L.P. (\"Invus IV US\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"InvOpps GP IV, L.L.C. (\"InvOpps GP\") is the sole general partner of each of Invus IV and Invus IV US. Sacha Lainovic is the managing member of InvOpps GP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Each of the Reporting Persons (other than to the extent it directly holds securities reported herein) disclaims beneficial ownership of the securities held by the other Reporting Persons, except to the extent of such Reporting Person's pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), each of the Reporting Persons (other than to the extent it directly holds securities reported herein) states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":609965,"source":{"system":"sec-edgar","filing":"0000899243-19-026771","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053891/000089924319026771/doc4.xml","form_type":"4"}},{"id":3873603,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":120944,"kind":"person","name":"LAINOVIC SACHA","position":1,"cik":"0001053891","reported_name":"LAINOVIC SACHA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-05T20:16:51.000Z","date":"2018-07-02","kind":"grant","acquired":true,"shares":187,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares listed represent shares of Common Stock subject to transfer restrictions."}],"balance_after":114894,"source":{"system":"sec-edgar","filing":"0001209191-18-041593","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919118041593/doc4.xml","form_type":"4"}},{"id":3971285,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":120944,"kind":"person","name":"LAINOVIC SACHA","position":1,"cik":"0001053891","reported_name":"LAINOVIC SACHA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-04T20:28:55.000Z","date":"2018-04-02","kind":"grant","acquired":true,"shares":295,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares listed represent shares of Common Stock subject to transfer restrictions."}],"balance_after":114707,"source":{"system":"sec-edgar","filing":"0001209191-18-023662","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919118023662/doc4.xml","form_type":"4"}},{"id":4109579,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":120944,"kind":"person","name":"LAINOVIC SACHA","position":1,"cik":"0001053891","reported_name":"LAINOVIC SACHA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-04T21:20:31.000Z","date":"2018-01-02","kind":"grant","acquired":true,"shares":390,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares listed represent shares of Common Stock subject to transfer restrictions."}],"balance_after":114412,"source":{"system":"sec-edgar","filing":"0001209191-18-001944","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919118001944/doc4.xml","form_type":"4"}},{"id":4193240,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":120944,"kind":"person","name":"LAINOVIC SACHA","position":1,"cik":"0001053891","reported_name":"LAINOVIC SACHA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-04T20:49:56.000Z","date":"2017-10-02","kind":"grant","acquired":true,"shares":435,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares listed represent shares of Common Stock subject to transfer restrictions."}],"balance_after":114022,"source":{"system":"sec-edgar","filing":"0001209191-17-055904","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919117055904/doc4.xml","form_type":"4"}},{"id":4262925,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":120944,"kind":"person","name":"LAINOVIC SACHA","position":1,"cik":"0001053891","reported_name":"LAINOVIC SACHA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-07-06T20:08:00.000Z","date":"2017-07-03","kind":"grant","acquired":true,"shares":569,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares listed represent shares of Common Stock subject to transfer restrictions."}],"balance_after":113587,"source":{"system":"sec-edgar","filing":"0001209191-17-043978","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919117043978/doc4.xml","form_type":"4"}},{"id":4359400,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":120944,"kind":"person","name":"LAINOVIC SACHA","position":1,"cik":"0001053891","reported_name":"LAINOVIC SACHA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-04-05T20:11:51.000Z","date":"2017-04-03","kind":"grant","acquired":true,"shares":1216,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares listed represent shares of Common Stock subject to transfer restrictions."}],"balance_after":113018,"source":{"system":"sec-edgar","filing":"0001209191-17-025606","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919117025606/doc4.xml","form_type":"4"}},{"id":4500593,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":120944,"kind":"person","name":"LAINOVIC SACHA","position":1,"cik":"0001053891","reported_name":"LAINOVIC SACHA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-05T21:16:39.000Z","date":"2017-01-03","kind":"grant","acquired":true,"shares":804,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares listed represent shares of Common Stock subject to transfer restrictions."}],"balance_after":111802,"source":{"system":"sec-edgar","filing":"0001209191-17-002030","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919117002030/doc4.xml","form_type":"4"}},{"id":4518009,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":120944,"kind":"person","name":"LAINOVIC SACHA","position":1,"cik":"0001053891","reported_name":"LAINOVIC SACHA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-19T21:09:19.000Z","date":"2016-12-15","kind":"grant","acquired":true,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares listed represent shares of Common Stock subject to transfer restrictions."}],"balance_after":110998,"source":{"system":"sec-edgar","filing":"0001209191-16-155882","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919116155882/doc4.xml","form_type":"4"}},{"id":4585653,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":120944,"kind":"person","name":"LAINOVIC SACHA","position":1,"cik":"0001053891","reported_name":"LAINOVIC SACHA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-10-05T20:16:47.000Z","date":"2016-10-03","kind":"grant","acquired":true,"shares":904,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares listed represent shares of Common Stock subject to transfer restrictions."}],"balance_after":109998,"source":{"system":"sec-edgar","filing":"0001209191-16-144905","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919116144905/doc4.xml","form_type":"4"}}]}